DOD issues notice of a TRICARE OTC project
The Department of Defense has issued a notice advising interested parties of a demonstration project in which the department will evaluate allowing selected OTCs to be included on the TRICARE uniform formulary.
The Department of Defense has issued a notice advising interested parties of a demonstration project in which the department will evaluate allowing selected OTCs to be included on the TRICARE uniform formulary. The demonstration project will be available for beneficiaries within the U.S., Puerto Rico, the Virgin Islands, and Guam. The notice appeared in the June 15 Federal Register. For more information, call (703) 681-2890.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
